Log in to save to my catalogue

Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening...

Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_268bc6e6fb0d40b4bc97db44e48c0587

Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants

About this item

Full title

Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants

Publisher

London: BioMed Central Ltd

Journal title

Hereditary cancer in clinical practice, 2021-08, Vol.19 (1), p.1-33, Article 33

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background The Australian Pancreatic Cancer Screening Program (APCSP) offers endoscopic ultrasound surveillance for individuals at increased risk of pancreatic ductal adenocarcinoma (PDAC) with all participants requiring assessment by a Familial Cancer Service before or after study enrolment. Methods Individuals aged 40-80 years (or 10 years younge...

Alternative Titles

Full title

Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_268bc6e6fb0d40b4bc97db44e48c0587

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_268bc6e6fb0d40b4bc97db44e48c0587

Other Identifiers

ISSN

1897-4287,1731-2302

E-ISSN

1897-4287

DOI

10.1186/s13053-021-00190-1

How to access this item